Media briefing on COVID-19 - 08/01/2021
Date:
08/01/2021
00:00:54
FC Hello, all. I think our technical problems are being solved now. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and I welcome you to our global COVID-19 press conference today, Friday 8th January. Present in the room are WHO Director-General, Dr Tedros, Dr Mike Ryan, Executive Director, Health Emergencies, Dr Maria Van Kerkhove, Technical Lead for COVID-19,...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/statistics & numerical data, Americas/epidemiology, Viral Vaccines/supply & distribution, Health Consortia, Access to Essential Medicines and Health Technologies, Healthcare Financing, Health Systems/organization & administration, Health Personnel, Risk Groups, Social Isolation, Masks, Quarantine, Epidemiological Monitoring, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 11/01/2021
Date:
11/01/2021
00:00:12
FC Hello, all. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and I welcome you to our global COVID-19 press conference today, Monday January 11th. Present in the room are Who Director-General, Dr Tedros, Dr Mike Ryan, Executive Director, health Emergencies, Dr Maria Van Kerkhove, Dr Mariangela Simao, Assistant Director-General, Access to Medicines and Health ...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Viral Vaccines/supply & distribution, Access to Essential Medicines and Health Technologies, Health Equity, Immunization Programs/organization & administration, Risk Groups, Health Personnel, Essential Public Health Functions, Social Isolation, Masks, Quarantine, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Acompanhe ao vivo nossa sessão virtual de perguntas e respostas sobre COVID-19. Tire suas dúvidas!
Date:
30/03/2021
Acompanhe ao vivo nossa sessão virtual de perguntas e respostas sobre COVID-19. Tire suas dúvidas!
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Social Isolation, Quarantine, Masks, Brazil/epidemiology, Risk Groups, Epidemiological Monitoring, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19
Coletiva de imprensa: anúncio do Governo - 17/02/2021
Date:
17/02/2021
O Governador João Doria confirmou nesta quarta-feira (17) que o Instituto Butantan vai antecipar a entrega de mais 54 milhões de doses da vacina contra o coronavírus ao Ministério da Saúde. A oferta da carga adicional de imunizantes será finalizada em agosto, totalizando 100 milhões de vacinas produzidas em São Paulo para todo o Brasil.
“Inicialmente prevista para o final de setembro, a ...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Local Health Systems/organization & administration, Schools/organization & administration, Psychology, Educational/organization & administration, Social Isolation, Masks, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Epidemiological Monitoring, Risk Groups, COVID-19, Plano São Paulo, Doria, João, Instituto Butantan, Sinovac Biotech, Coronavac, Município de Serrana , Projeto S, Psicólogos na escola
Coletiva de imprensa: anúncios do Governo SP - 17/12/2020
Date:
17/12/2020
O Governador João Doria anunciou a chegada, nesta quinta-feira (17), de 2 milhões de doses prontas da vacina contra o coronavírus, a Coronavac, desenvolvida em parceria com o Instituto Butantan. Trata-se do maior lote de vacinas que chega à América do Sul até o momento.
“A pressa pela vacina é a pressa pela vida. Todos os brasileiros de bem têm pressa. São Paulo, reafirmo aqui, começar...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Brazilian Health Surveillance Agency, Holidays, Epidemiological Monitoring, Clinical Trial, Phase III, Immunization Programs/organization & administration, Public-Private Sector Partnerships/organization & administration, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Masks, Social Isolation, Schools/standards, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 14/12/2020
Date:
14/12/2020
O Governador João Doria confirmou nesta segunda-feira (14) que o estudo clínico conclusivo da vacina do Instituto Butantan contra o coronavírus será divulgado no dia 23 de dezembro. A medida dá mais agilidade aos trâmites de certificação na Anvisa (Agência Nacional de Vigilância Sanitária) e demais órgãos internacionais de saúde.
“Os brasileiros querem agilidade, querem as vacinas ...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Epidemiological Monitoring, Immunization Programs/organization & administration, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Healthy Volunteers, Governmental Research Institutes, Risk Groups, Police/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/statistics & numerical data, Social Isolation, Masks, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Horário de funcionamento dos bares é reduzido
Date:
11/12/2020
Saiba mais em www.saopaulo.sp.gov.br/coronavirus/planosp
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Quarantine/organization & administration, Restaurants/standards, Social Isolation, Masks, Epidemiological Monitoring, COVID-19, Plano São Paulo
Coletiva de imprensa: anúncios da Saúde no combate ao Coronavírus
Date:
11/12/2020
Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Risk Groups, Masks, Social Isolation, Local Health Systems/organization & administration, Healthcare Financing, Quarantine/organization & administration, Commerce/organization & administration, Carrier State/transmission, Brazilian Health Surveillance Agency, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Media briefing on COVID-19 - 11/12/2020
Date:
11/12/2020
00:03:06
FC Hello, everybody. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Friday 11th December. Present in the room are the WHO Director-General, Dr Tedros, Dr Mike Ryan, Executive Director, Health Emergencies, Dr Maria Van Kerkhove, Technical Lead for COVID-19, Dr Ed Kelley, Director, Integrated Heal...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, United Kingdom, Access to Essential Medicines and Health Technologies, Healthcare Financing, Health Systems/economics, Gift Giving, Human Rights, Universal Health Coverage, Schools/standards, 50207, Holidays, Masks, Social Isolation, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Epidemiological Monitoring, COVID-19, Covax, Ghebreyesus, Tedros Adhanom
Media briefing on COVID-19 - 04/12/2020
Date:
04/12/2020
00:00:26
TJ Good evening, everyone, from Geneva, WHO headquarters. My name is Tarik and I'm happy to be back at these press conferences; it's been five months. Welcome to another regular WHO COVID-19 press briefing. We have a number of speakers here in the room but also we will have some guests whom Dr Tedros will introduce in a moment. In the room with us we have WHO Director-General, D...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Social Isolation, Masks, Americas/epidemiology, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Hospital Bed Capacity, Intensive Care Units/supply & distribution, Hospitals/supply & distribution, Health Personnel/organization & administration, 50207, Access to Essential Medicines and Health Technologies, Investments/economics, Decision Making, Risk Groups, Mutation/genetics, Betacoronavirus/genetics, Vaccine Potency, Clinical Trial, COVID-19, Ghebreyesus, Tedros Adhanom, Pfizer, Reino Unido, BioNTech, BNT162, Covax
